Specific intranasal and central trigeminal electrophysiological responses in Parkinson’s disease

被引:0
|
作者
Cécilia Tremblay
Rosa Emrich
Annachiara Cavazzana
Lisa Klingelhoefer
Moritz D. Brandt
Thomas Hummel
Antje Haehner
Johannes Frasnelli
机构
[1] Université du Québec à Trois-Rivières (UQTR),Research Chair in Chemosensory Neuroanatomy, Department of Anatomy
[2] Smell and Taste Clinic,Department of Otorhinolaryngology
[3] Technical University of Dresden,Department of Neurology
[4] TU Dresden,undefined
[5] German Center for Neurodegenerative Diseases (DZNE),undefined
[6] Research Center of the Sacré-Cœur Hospital,undefined
来源
Journal of Neurology | 2019年 / 266卷
关键词
Parkinson’s disease; Olfactory dysfunction; Trigeminal system; Negative-mucosa potential; Event-related potential;
D O I
暂无
中图分类号
学科分类号
摘要
Olfactory dysfunction is a frequent early non-motor symptom of Parkinson’s disease (PD). There is evidence that with regard to trigeminal perception, PD-related olfactory dysfunction is different from other olfactory disorders. More specifically, trigeminal sensitivity, when measured behaviorally, was unimpaired in PD patients as opposed to patients with non-Parkinsonian olfactory dysfunction (NPOD). We sought to investigate the trigeminal pathway by measuring electrophysiological recordings from the nasal epithelium and EEG-derived event-related potentials in response to a specific trigeminal stimulus in 21 PD patients and compare them to 23 patients with NPOD and 25 controls (C). The peripheral trigeminal response, as measured by the negative-mucosa potential, showed no difference between patients with PD and controls whereas PD patients showed faster responses than patients with NPOD, the latter having shown slower and larger responses than controls (18 PD, 14 NPOD, 20 C). The central trigeminal response, as measured by event-related potentials, revealed larger early component response in PD patients compared to patients with NPOD (15 PD, 21 NPOD, 23 C). As expected, psychophysical olfactory testing showed impaired olfactory function in both groups of patients as opposed to controls. Discriminant analysis revealed a model that could predict group membership for 80% of participants based on the negative-mucosa potential latency, olfactory threshold and discrimination tests. These results provide novel insights into the pattern of trigeminal activation in PD which will help to differentiate PD-related olfactory loss from NPOD, a crucial step towards establishing early screening batteries for PD including smell tests.
引用
收藏
页码:2942 / 2951
页数:9
相关论文
共 50 条
  • [41] Pisa syndrome in Parkinson’s disease: an electrophysiological and imaging study
    Michele Tinazzi
    Ina Juergenson
    Giovanna Squintani
    Gaetano Vattemi
    Stefania Montemezzi
    Daniela Censi
    Paolo Barone
    Tommaso Bovi
    Alfonso Fasano
    Journal of Neurology, 2013, 260 : 2138 - 2148
  • [42] ELECTROPHYSIOLOGICAL CHARACTERISTICS OF TREMOR IN ESSENTIAL TREMOR AND PARKINSON'S DISEASE
    Sabirova, A.
    Rakhimbaeva, G.
    Ergasheva, M.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E115 - E115
  • [43] Asymptomatic autonomic dysfunction in Parkinson's Disease - an electrophysiological study
    Umaiorubahan, M
    Uthamarayan, V
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S374 - S374
  • [44] Analysis of electrophysiological data in surgical treatment for Parkinson's disease
    Hamilton, JL
    Micheli-Tzanakou, E
    Lehman, R
    PROCEEDINGS OF THE IEEE 24TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, 1998, : 5 - 6
  • [45] Electrophysiological markers for emotional and cognitive impairment in Parkinson's disease
    Dissanayaka, N.
    Au, T.
    Angwin, A.
    O'Sullivan, J.
    Byrne, G.
    Silburn, P.
    Marsh, R.
    Mellick, G.
    Copland, D.
    MOVEMENT DISORDERS, 2017, 32
  • [46] A specific immune response in Parkinson's Disease indicates central dopaminergic cell death
    Rowe, DB
    Double, KL
    Griffiths, F
    Chan, D
    Reiderer, P
    Gerlach, M
    NEUROLOGY, 2001, 56 (08) : A342 - A342
  • [47] Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
    Saha, Paramita
    Kathuria, Himanshu
    Pandey, Murali Monohar
    JOURNAL OF CONTROLLED RELEASE, 2023, 358 : 293 - 318
  • [48] A Potential Strategy for Treating Parkinson's Disease Through Intranasal Nanoemulsions
    Shirsath, Krushna
    Agrawal, Yogeeta O.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (08) : 1137 - 1145
  • [49] Intranasal GDNF for Parkinson's Disease: Next steps in preclinical development
    Waszczak, Barbara Lee
    Wachtman, Lynn
    Newsome, Ginnifer C.
    Aly, Amirah
    Silva, Nilsa
    Westmoreland, Susan
    Rowlett, James
    Migliore, Mattia M.
    FASEB JOURNAL, 2013, 27
  • [50] Hypoxia Sensing and Responses in Parkinson's Disease
    Burtscher, Johannes
    Duderstadt, Yves
    Gatterer, Hannes
    Burtscher, Martin
    Vozdek, Roman
    Millet, Gregoire P.
    Hicks, Andrew A.
    Ehrenreich, Hannelore
    Kopp, Martin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)